Something new is coming to help heart failure management.
This new, connected patient experience has the potential to unlock clinician-led patient self-management.
Built on the proven outcomes of the CardioMEMS™ HF System
10+ years
Over a decade of real-world experience1
50,000+ patients
Over 50,000 patients implanted1
3 RCTs
Proven in three randomized control trials2-4
The CardioGuide™ HF App is designed to guide* what's next
- Informing and engaging patients
- Streamlining communication
- Personalizing patient management
Sign up to get the latest information on the CardioGuide HF App
CardioMEMS™ HF System and CardioGuide™ HF App are not currently available in all countries. Please contact your Abbott representative for information on availability in your area.
*The CardioGuide™ HF App is intended to support patient engagement and communication. “Guide” refers to the CardioGuide™ HF App experience and does not imply changes to the indications for use or operation of the CardioMEMS™ HF System.
- Abbott. Data on file.
- Abraham WT, Adamson PB, Bourge RC, et al. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomized controlled trial. The Lancet. 2011;377(9766):658-666.
- Brugts JJ, Radhoe SP, Clephas PRD, et al. Remote haemodynamic monitoring of pulmonary artery pressures in patients with chronic heart failure (MONITOR-HF): a randomised clinical trial. The Lancet. 2023;401(10394):2113-2123. doi:10.1016/S0140-6736(23)00923-6
- Lindenfeld J, Zile MR, Desai AS, et al. Haemodynamic-guided management of heart failure (GUIDE-HF): a randomized controlled trial. The Lancet. 2021;398:991-1001.
MAT-2678854 v1.0